Gloria Perazzoli
Gloria Perazzoli
Dirección de correo verificada de ugr.es
TítuloCitado porAño
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
C Melguizo, J Prados, B González, R Ortiz, A Concha, PJ Alvarez, ...
Journal of translational medicine 10 (1), 250, 2012
662012
Temozolomide resistance in glioblastoma cell lines: implication of MGMT, MMR, P-glycoprotein and CD133 expression
G Perazzoli, J Prados, R Ortiz, O Caba, L Cabeza, M Berdasco, ...
PloS one 10 (10), e0140131, 2015
642015
Sigma-1 receptor inhibition reverses acute inflammatory hyperalgesia in mice: role of peripheral sigma-1 receptors
MÁ Tejada, Á Montilla-García, C Sánchez-Fernández, JM Entrena, ...
Psychopharmacology (Berl) 231 (19), 3855-3869, 2014
332014
Mechanistic differences in neuropathic pain modalities revealed by correlating behavior with global expression profiling
EJ Cobos, CA Nickerson, F Gao, V Chandran, I Bravo-Caparrós, ...
Cell reports 22 (5), 1301-1312, 2018
232018
Colon cancer therapy: recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs
J Prados, C Melguizo, R Ortiz, G Perazzoli, L Cabeza, P J Alvarez, ...
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2013
222013
Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly (ε-caprolactone) nanoparticles in lung and breast cancer treatment: an in vitro and in vivo …
L Cabeza, R Ortiz, J Prados, ÁV Delgado, MJ Martín-Villena, B Clares, ...
European Journal of Pharmaceutical Sciences 102, 24-34, 2017
182017
Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patents
J Prados, C Melguizo, G Perazzoli, L Cabeza, E Carrasco, J Oliver, ...
Recent patents on anti-cancer drug discovery 9 (1), 21-34, 2014
132014
Specific colon cancer cell cytotoxicity induced by bacteriophage E gene expression under transcriptional control of carcinoembryonic antigen promoter
A Rama, R Hernandez, G Perazzoli, M Burgos, C Melguizo, C Vélez, ...
International journal of molecular sciences 16 (6), 12601-12615, 2015
122015
Paclitaxel-loaded hollow-poly (4-vinylpyridine) nanoparticles enhance drug chemotherapeutic efficacy in lung and breast cancer cell lines
R Contreras-Cáceres, MC Leiva, R Ortiz, A Díaz, G Perazzoli, ...
Nano Research 10 (3), 856-875, 2017
82017
Grip strength in mice with joint inflammation: A rheumatology function test sensitive to pain and analgesia
Á Montilla-García, MÁ Tejada, G Perazzoli, JM Entrena, E Portillo-Salido, ...
Neuropharmacology 125, 231-242, 2017
72017
Modality-specific peripheral antinociceptive effects of μ-opioid agonists on heat and mechanical stimuli: contribution of sigma-1 receptors
Á Montilla-García, G Perazzoli, MA Tejada, R González-Cano, ...
Neuropharmacology 135, 328-342, 2018
52018
Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro
MC Leiva, R Ortiz, R Contreras-Cáceres, G Perazzoli, I Mayevych, ...
Scientific reports 7 (1), 13506, 2017
42017
Last advances in nanocarriers-based drug delivery systems for colorectal cancer
A R Rama, J Jimenez-Lopez, L Cabeza, C Jimenez-Luna, M C Leiva, ...
Current drug delivery 13 (6), 830-838, 2016
42016
Electrospun Nanofibers: Recent Applications in Drug Delivery and Cancer Therapy
R Contreras-Cáceres, L Cabeza, G Perazzoli, A Díaz, JM López-Romero, ...
Nanomaterials 9 (4), 656, 2019
22019
Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy
C Lorente, L Cabeza, B Clares, R Ortiz, L Halbaut, ÁV Delgado, ...
Colloids and Surfaces B: Biointerfaces 171, 553-565, 2018
22018
Nanotechnology for ocular and otic drug delivery and targeting
AA Attama, C Lovelyna, EB Onuigbob
Nanotechnology and Drug Delivery, Volume Two: Nano-Engineering Strategies …, 2016
22016
57P The expression of MMR, CD133 and the presence of p53 wt predict the response to cabazitaxel in malignant neural tumours cell lines
K Doello, C Mesas, G Perazzoli, C García-Collado, MJ Gándara, ...
Annals of Oncology 30 (Supplement_5), mdz238. 055, 2019
2019
Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer
AR Rama, R Hernández, G Perazzoli, L Cabeza, C Melguizo, C Vélez, ...
Cancer gene therapy, 1-12, 2019
2019
O6-methylguanine-DNA Methyltransferase Promoter Methylation in Patients with Rectal Adenocarcinoma After Chemoradiotherapy Treatment: Clinical Implications
JA Oliver, J Gómez-Millán, JA Medina, L Cabeza, G Perazzoli, ...
Balkan Medical Journal 36 (5), 283, 2019
2019
Nanoformulations for glioblastoma multiforme: a new hope for treatment
R Ortiz, L Cabeza, G Perazzoli, J Jimenez-Lopez, B García-Pinel, ...
Future medicinal chemistry, 2019
2019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20